COVID-19 Pandemic Spurs Evolution of an Academic Pathology Department and Laboratory

Abstract

The COVID-19 pandemic has caused much suffering through disease and death, disruption of daily life, and economic havoc. Global health infrastructure has been challenged, in some cases failing. In the United States, the inability of laboratories to provide adequate testing for the causative pathogen, severe acute respiratory syndrome coronavirus 2, has been the subject of negative press and national debate. Even so, these challenges have prompted pathology practices and clinical labs to change their organizations and operations for the better. The natural positive evolution of the University of Oklahoma Department of Pathology and OU Health Laboratories has been greatly accelerated by the global pandemic. While developing a substantial COVID testing response, our department of pathology and laboratories have evolved a much nimbler organizational structure, established an important research partnership, built a translational research resource, created a significant reference lab capability, and completed many key hires against a national background of hiring freezes and pay cuts. Also, the high visibility of the clinical lab and pathologists during the outbreak has reinforced the value of lab medicine to patient care across our health system. In the midst of significant ongoing changes to the structure and financing of our underlying organizations, high trust among departmental, hospital, health system, and medical school leadership during the pandemic has promoted these positive changes, allowing us to emerge much stronger from this crisis.

Communication during a global pandemic: The utility of a professional society listserv and journal

“…The SARS-coronavirus −2 (SARS-CoV-2, COVID-19) global pandemic has presented heretofore unimaginable challenges to the field of medicine overall but particularly to the discipline of pathology, which has been thrust onto the front line for development, performance, and reporting of diagnostic and surveillance testing while maintaining support services for nonpandemic patients. 1 , 2 , 3 , 4 , 5 , 6 …”